Chronic eczematous eruptions in the aging: Further support for an association with exposure to calcium channel blockers

JAMA Dermatology

Volumn 149, Issue 7, 2013, Pages 814-818

  Summers, Erika M ^a   Bingham, Colby S ^a   Dahle, Kevin W ^b   Sweeney, Carol ^a   Ying, Jian ^a   Sontheimer, Richard D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; THYROID HORMONE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC ECZEMATOUS ERUPTION IN THE AGING; CONTROLLED STUDY; DERMATITIS; DERMATOLOGY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG USE; ECZEMA; ELDERLY CARE; ETHNICITY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; INTERFACE DERMATITIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN BIOPSY; SPONGIOTIC DERMATITIS;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CONFIDENCE INTERVALS; DRUG ERUPTIONS; ECZEMA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; THIAZIDES; UNITED STATES;

EID: 84880637657     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.511     Document Type: Article

References (10)

1. Morin C, Joly P, Courville P, et al. Chronic eczematiform eruption in the elderly. Ann Dermatol Venereol. 2002;129(1, pt 1):19-22.
2. Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study. J Invest Dermatol. 2007;127(12):2766-2771.
3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3): 337-344.
4. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867-2878.
5. Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: a 5-year experience. J Am Acad Dermatol. 2008;59(6):995-999.
6. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62(6): 493-504.
7. Stern RS. Chronic medication use and inflammatory skin diseases: the power and limitations of the case-control study. J Invest Dermatol. 2007;127(12):2709-2710.
8. Lochmatter P, Zawodniak A, Pichler WJ. In vitro tests in drug hypersensitivity diagnosis. Immunol Allergy Clin North Am. 2009;29(3):537-554.
9. Padial A, Antunez C, Blanca-Lopez N, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy. 2008;38(5): 822-828.
10. Torres MJ, Romano A, Mayorga C, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy. 2001;56(9):850-856.